Wolters Kluwer

Slight revisions to the outlook overshadow the good Q3 results

30/10/24 -"Wolters Kluwer released impressive 9M results, with continuous strong organic revenue growth and profitability figures. However, although the guidance was reiterated at the group level, Health ..."

PDF page sample
Pages
57
Language
English
Published on
30/10/24
Download
You may also be interested by these reports :
12/03/25
Our EPS for 2025 and 2026 have been downgraded mainly due to higher minorities as Informa is continuing down the partnership path. We have thus ...
06/03/25
ITV released disappointing FY24 figures, but the CEO declined to comment on any bid speculation, fuelling hope of a unit sale or a takeover. The ...
06/03/25
Informa disclosed FY24 results that were above expectations, but the unusually foggy outlook for 2025 seems to imply an unknown trade conflict ...
06/03/25
The group reported satisfactory results, allowing it to resume dividend payments. After years of challenges, JC Decaux has returned to pre-pandemic ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO